MIST Milestone Pharmaceuticals Inc Future Price to Earnings

The historical price chart for Milestone Pharmaceuticals (MIST) demonstrates P/E dynamics, which currently stand at 0.00. The business relies on the development of cardiology medications in North American centers, protecting its positions with patents for anti-arrhythmia agents. Stability is guaranteed by a strong staff of biochemists with zero turnover, while the company is actively recruiting clinical trial specialists.

MIST - Milestone Pharmaceuticals Inc. Projected Price to Earnings Ratio over the range 07/04/2022 - 11/12/2026

Comprehensive metric breakdowns and analytics for Milestone Pharmaceuticals Inc (MIST)

- stock quotes and analyst forecast:

Stock Price Milestone Pharmaceuticals Inc.|MIST - Analyst Median Target

- market capitalization data:

Market Value Milestone Pharmaceuticals, Inc.|MIST - Total Company Value

- balance sheet equity data:

Book Value per Share Milestone Pharmaceuticals|MIST - Total Stockholders' Equity|Market Value to Book Value Ratio milestonepharma.com|MIST - Company Total Asset Base

- debt obligations and liquidity statistics:

Total Debt to Equity Ratio Milestone Pharmaceuticals|MIST - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Milestone Pharmaceuticals|MIST - Company Cumulative Debt|Debt to Book Capitalization Ratio Milestone Pharmaceuticals, Inc.|MIST - Company Long-Term Indebtedness|Company Short-Term Debts Milestone Pharmaceuticals|Quick Liquidity Indicator milestonepharma.com

- earnings and market ratios statistics:

MIST - Final Profit|Expected Profit Milestone Pharmaceuticals|MIST - Market Cap to Net Income|Forward P/E Multiple Milestone Pharma|MIST - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Milestone Pharmaceuticals, Inc.|MIST - Operating profit EBITDA|Earnings per share for the last twelve months Milestone Pharmaceuticals|MIST - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months milestonepharma.com|MIST - Net earnings per share growth this year|Earnings growth forecast for next year Milestone Pharmaceuticals

Analysis of all company metrics:MIST Milestone Pharmaceuticals Inc.

Product sample of Milestone Pharmaceuticals

Milestone Pharmaceuticals (MIST) is integrating ESG principles into the development of cardiology drugs, optimizing laboratory resources and bioethics. The company's forward P/E valuation compares the current market value of the business with expected annual earnings. This ratio determines the extent to which an investor is overpaying for future income. Analyzing the dynamics allows for a balance between drawdown risks and growth potential. The trajectory of this chart serves as an indicator of the fundamental fairness of the market price.

Who Milestone Pharmaceuticals competes with